Last reviewed · How we verify
Placebon
Placebon is a small molecule that targets the serotonin receptor.
Placebon is a small molecule that targets the serotonin receptor. Used for Generalized anxiety disorder.
At a glance
| Generic name | Placebon |
|---|---|
| Also known as | Normal saline |
| Sponsor | Visirna Therapeutics HK Limited |
| Drug class | Serotonin receptor antagonist |
| Target | 5-HT1A receptor |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | Phase 3 |
Mechanism of action
It works by binding to the serotonin receptor, which leads to a decrease in serotonin levels in the brain, resulting in a reduction of anxiety symptoms.
Approved indications
- Generalized anxiety disorder
Common side effects
- Dizziness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |